| Literature DB >> 35281220 |
Abstract
Virtual Reality Exposure Therapy (VRET) has been shown to be an effective technique for reducing social anxiety. People who stutter are at greater risk of developing heightened social anxiety. Cognitive behavior therapy protocols have shown promise in reducing social anxiety in people who stutter, but no studies have investigated VRET targeting social anxiety associated with stuttering. The aim of the current review is to provide an overview of VRET techniques used to treat social anxiety and insights into how these techniques might be adopted in the case of comorbid stuttering and social anxiety. Twelve studies were reviewed to understand key distinctions in VRET protocols used to treat social anxiety. Distinctions include exercises targeting public speaking vs. general social anxiety, computer-generated virtual environments vs. 360° video, and therapist guided vs. automated VRET. Based on the review findings, we propose how certain features could be applied in the case of stuttering. Virtual therapists, inhibitory learning techniques and integration into speech therapy may be suitable ways to tailor VRET. Regardless of these different techniques, VRET should consider the situations and cognitive-behavioral processes that underlie the experience of social anxiety amongst people who stutter.Entities:
Keywords: VRET; social anxiety; social phobia; stammering; stuttering; virtual reality
Year: 2022 PMID: 35281220 PMCID: PMC8913509 DOI: 10.3389/fdgth.2022.842460
Source DB: PubMed Journal: Front Digit Health ISSN: 2673-253X
Figure 1PRISMA-ScR diagram.
Studies included in scoping review, methodological details, and key features of VRET protocols.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anderson et al. ( | 39 | 30 | 39 | 28 | IVET, WL | FNE-B, PRCS, peak anxiety during speech, speech length | Yes | PSA | Unknown | Computer-generated | Yes | Unknown | Real | Yes |
| Anderson et al. ( | 42 | 13 | 15 | IVET | FNE-B, PRCS, peak anxiety during speech, speech length | Yes | PSA | Unknown | Computer-generated | Yes | Unknown | Real | Yes | |
| Bouchard et al. ( | 34.5 | 17 | 22 | 20 | CBT-IV, WL | LSAS-SR, SPS, SIAS, FNE, BAT (SPRS) | Yes | General SA | Inhibitory learning | Computer-generated | Yes | Research-grade HMD | Real | Yes |
| Harris et al. ( | Unknown | 8 | 6 | WL | LSAS, PRCS, STAI, ATPS, HR during voice sample | No | PSA | Unknown | Unknown | Unknown | Research-grade HMD | Real | No | |
| Kampmann et al. ( | 36.9 | 20 | 20 | 20 | IVET, WL | LSAS-SR, FNE-B, speech duration, speech performance | Yes | General SA | Emotional processing | Computer-generated | Unknown | Research-grade HMD | Real | No |
| Klinger et al. ( | 32 | 18 | 18 | CBT-IV | LSAS, RAS | Yes | General SA | Unknown | Computer-generated | Yes | Monitor | Real | Unknown | |
| Lindner et al. ( | 31.4 | 25 | 25 | WL | PSAS, LSAS-SR, FNE-B | Yes | PSA | Inhibitory learning | 360° video | Unknown | Smartphone HMD | Real | No | |
| Reeves et al. ( | 26.1 | 17 (Audience), 16 (Empty room) | 18 | WL | PSAS, LSAS-SR, FNE-B, speech duration | No | PSA | Unknown | 360° video | Yes | Smartphone HMD | None | No | |
| Robillard et al. ( | 34.9 | 14 | 16 | 15 | CBT-IV, WL | LSAS, SPS, ASC-P, ASC-C, FNE | Yes | General SA | Unknown | Computer-generated | Yes | Research-grade HMD | Real | Yes |
| Safir et al. ( | 27 | 25 | 24 | CBT-IV | LSAS, SSPS, FNE, self- and observer-rated anxiety during speech | No | PSA | Unknown | Computer-generated | Unknown | Research-grade HMD | Real | Yes | |
| Wallach et al. ( | 27 | 28 | 30 | 30 | CBT-IV, WL | LSAS, SSPS, FNE, self- and observer-rated anxiety during speech | No | PSA | Unknown | Computer-generated | Unknown | Research-grade HMD | Real | Yes |
| Zainal et al. ( | 23.3 | 26 | 18 | WL | SPDQ, SIAS, MASI | Yes | General SA | Emotional processing | 360° video | Unknown | Consumer HMD | Virtual | No |
IVET, in vivo exposure therapy; WL, waitlist; CBT-IV, CBT with in vivo exposure therapy; FNE-B, fear of negative evaluation—brief form (.
Key features of studies included in the scoping review.
|
|
|
|---|---|
| Anderson et al. ( | • Participants had a clinical diagnosis of SAD |
| Bouchard et al. ( | • Participants had a clinical diagnosis of SAD |
| Harris et al. ( | • Participants did not have a clinical diagnosis of SAD, but had elevated levels of social anxiety |
| Kampmann et al. ( | • Participants had a clinical diagnosis of SAD |
| Klinger et al. ( | • Participants had a clinical diagnosis of SAD |
| Lindner et al. ( | • Participants had clinical levels of public speaking anxiety |
| Reeves et al. ( | • Participants had subclinical levels of social anxiety |
| • 360° video virtual environments | |
| Robillard et al. ( | • Participants had subclinical levels of public speaking anxiety |
| Safir et al. ( | • Participants had subclinical levels of public speaking anxiety |
| Zainal et al. ( | • Participants had a clinical diagnosis of SAD |